시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
체외수정(IVF) 시장 규모, 점유율, 예측 및 동향 분석 : 유형별, 제품별, 주기별, 용도별, 최종 사용자별 - 세계 예측(-2031년)
In Vitro Fertilization Market Size, Share, Forecast, & Trends Analysis by Type (Natural, Intracytoplasmic, Minimal), Product (Imaging, Cryosystems, IVF Cabinets, Incubator, Media, Sperm Analyzer), Cycle, Application, End User - Global Forecast to 2031
상품코드 : 1504230
리서치사 : Meticulous Research
발행일 : On Demand Report
페이지 정보 : 영문 275 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,175 ￦ 6,224,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회만 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,875 ￦ 8,758,000
PDF (Multi User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,875 ￦ 11,740,000
PDF (Global Site License) help
PDF 보고서를 동일 기업 및 자회사의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

체외수정(IVF) 시장은 2024-2031년간 연평균 7.1%의 연평균 복합 성장률(CAGR)로 2031년까지 42억 달러에 달할 것으로 예상됩니다.

이 보고서는 광범위한 2차 및 1차 연구와 시장 시나리오에 대한 심층 분석을 통해 주요 산업 촉진요인, 시장 성장 억제요인, 기회 및 과제에 대한 분석을 제공합니다. 체외수정(IVF) 시장의 성장은 주로 불임률 증가, 체외수정 시술의 기술적 진보, 체외수정의 높은 임신 성공률, 사회문화적 규범의 변화, 유리한 정부 규제 및 정책, 체외수정의 비용 절감에 의해 주도되고 있습니다. 그러나 난소과자극증후군, 다태아 임신 등 체외수정 시술에 따른 건강 위험과 합병증, 실패한 주기의 위험은 이 시장의 성장을 저해하는 요인입니다.

또한, 최상의 배아를 선택하기 위한 착상 전 유전자 검사(PGT)에 대한 접근성이 높아짐에 따라 체외수정(IVF) 시장 기업들에게 성장 기회를 제공할 것으로 예상됩니다. 하지만, 특히 지방의 경우 체외수정 전문 클리닉의 수가 제한적이고, 체외수정으로 태어난 아이의 선천성 기형 위험은 체외수정(IVF) 시장의 큰 도전과제로 작용하고 있습니다. 또한, 선택적 난자 동결, 선택적 단배아 이식, 체외수정 치료에 AI의 통합은 체외수정(IVF) 시장에서 두드러진 추세입니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 인사이트

제5장 체외수정(IVF) 시장 : 제품별 평가

제6장 체외수정(IVF) 시장 : 유형별 평가

제7장 체외수정(IVF) 시장 : 사이클별 평가

제8장 체외수정(IVF) 시장 : 용도별 평가

제9장 체외수정(IVF) 시장 : 최종사용자별 평가

제10장 체외수정(IVF) 시장 : 지역별 평가

제11장 경쟁 분석

제12장 기업 개요(기업 개요, 재무 개요, 제품 포트폴리오, 전략적 전개, SWOT 분석*)

(*주 : SWOT 분석은 주요 5개사에 대해 제공)

제13장 부록

LSH
영문 목차

영문목차

The In Vitro Fertilization (IVF) market is projected to reach $4.20 billion by 2031 at a CAGR of 7.1% from 2024 to 2031.

After extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges. The growth of the IVF market is primarily driven by increasing infertility rates, technological advancements in IVF procedures, the high success rates of pregnancy through IVF, changing socio-cultural norms, favorable government regulations & policies, and the reducing costs of IVF. However, the health risks & complications associated with IVF treatment, such as ovarian hyperstimulation syndrome and multiple pregnancies, and the risk of unsuccessful cycles restrain the growth of this market.

Furthermore, the increasing access to Preimplantation Genetic Testing (PGT) for selecting the best embryos is expected to offer growth opportunities for the players operating in the IVF market. However, the limited availability of specialized IVF clinics, especially in rural areas, and the risk of birth defects in babies born through IVF are major challenges in the IVF market. Additionally, elective egg freezing, elective single-embryo transfers, and the integration of AI in IVF treatment are prominent trends in the IVF market.

The report offers a competitive landscape based on an extensive assessment of the leading players' product portfolios, geographic presence, and key strategies adopted over the last four years (2020-2024). The key players operating in the in vitro fertilization market are Esco Micro Pte. Ltd. (Singapore), Vitrolife Sweden AB (Sweden), Thermo Fisher Scientific Inc. (U.S.), Rocket Medical plc (U.K.), Kitazato Corporation (Japan), CooperSurgical, Inc. (U.S.), FUJIFILM Irvine Scientific. (U.S.), Hamilton Thorne Inc. (U.S.), Carl Zeiss AG (Germany), FERTIPRO NV (Belgium), and The Baker Company (U.S.).

Among all the products studied in this report, in 2024, the instruments segment is expected to account for the largest share of 62.9% of the in vitro fertilization market. The instruments segment is further categorized into imaging systems, ovum aspiration pumps, micromanipulator systems, gas analyzers, incubators, laser analyzers, cryosystems, sperm separation devices, sperm analyzer systems, sterile cabinets, and other instruments. The rising demand for advanced IVF instruments, high affordability in the private sector, the increasing number of fertility clinics, and rising healthcare expenditures support the segment's large market share.

Among all the applications studied in this report, in 2024, the human reproduction segment is expected to account for the major share of the in vitro fertilization market. The segment's large share is attributed to the increasing demand for IVF due to increasing pregnancy success rates through IVF, rising healthcare expenditures, the increasing demand for IVF due to changing socio-demographic trends, the availability of modern technologies, and decreasing natural fertility rates. For instance, according to the World Health Organization's April 2023 Report, 1 in 6 people globally are affected by infertility.

Based on end user, the IVF market is segmented into hospitals, fertility clinics, research institutes, and cryobanks. In 2024, the fertility clinics segment is expected to account for the largest share of the in vitro fertilization market. The large share of this segment is attributed to the increased adoption of advanced techniques in fertility clinics for the treatment of infertility. Additionally, fertility clinics have specialized expertise and also offer a comprehensive range of services beyond IVF, including counseling and egg freezing. The rising demand for IVF treatments and the increasing number of IVF clinics worldwide are further supporting the segment's large share. For instance, according to the National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health (U.S.), there are approximately 500 fertility clinics in the U.S.

An in-depth analysis of the geographical scenario of the global IVF market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of 42.0% of the in vitro fertilization market. North America's large market share is attributed to the availability of advanced infrastructure, high healthcare expenditures, favorable policies, and the presence of key players with well-established distribution channels in the region. However, Asia-Pacific is expected to register the highest CAGR of 9.4% during the forecast period due to the growing number of individuals with infertility, changing socio-cultural norms, increasing healthcare expenditures, and increasing access to fertility clinics in the region.

Scope of the Report:

In Vitro Fertilization Market Assessment-by Product

Note: Other Instruments include anti-vibration tables, air purification systems, witness systems, glass heaters, and tube warmers.

Note: Other accessories include dishes, pipettes, tubes, sperm-counting chambers, shelves, and microscope slides.

In Vitro Fertilization Market Assessment-by Type

Note: Other types include needle-free IVF, ovarian rejuvenation therapy, and egg freezing.

In Vitro Fertilization Market Assessment-by Cycle

In Vitro Fertilization Market Assessment-by Application

In Vitro Fertilization Market Assessment-by End User

In Vitro Fertilization Market Assessment-by Geography

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Insights

5. In Vitro Fertilization Market Assessment-by Product

6. In Vitro Fertilization Market Assessment-by Type

7. In Vitro Fertilization Market Assessment-by Cycle

8. In Vitro Fertilization Market Assessment-by Application

9. In Vitro Fertilization Market Assessment-by End User

10. In Vitro Fertilization Market Assessment-by Geography

11. Competition Analysis

12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

(*Note: SWOT analysis will be provided for the top 5 companies.)

13. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기